ES2277437T3 - Vacuna combinada contra la hepatitis a y la hepatitis b. - Google Patents

Vacuna combinada contra la hepatitis a y la hepatitis b. Download PDF

Info

Publication number
ES2277437T3
ES2277437T3 ES99924871T ES99924871T ES2277437T3 ES 2277437 T3 ES2277437 T3 ES 2277437T3 ES 99924871 T ES99924871 T ES 99924871T ES 99924871 T ES99924871 T ES 99924871T ES 2277437 T3 ES2277437 T3 ES 2277437T3
Authority
ES
Spain
Prior art keywords
hepatitis
aluminum
mug
antigen
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99924871T
Other languages
English (en)
Spanish (es)
Inventor
Claude Artois
Michael J. Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of ES2277437T3 publication Critical patent/ES2277437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES99924871T 1998-05-01 1999-04-27 Vacuna combinada contra la hepatitis a y la hepatitis b. Expired - Lifetime ES2277437T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9809507 1998-05-01
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition

Publications (1)

Publication Number Publication Date
ES2277437T3 true ES2277437T3 (es) 2007-07-01

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99924871T Expired - Lifetime ES2277437T3 (es) 1998-05-01 1999-04-27 Vacuna combinada contra la hepatitis a y la hepatitis b.

Country Status (28)

Country Link
EP (1) EP1073462B1 (enExample)
JP (2) JP5138843B2 (enExample)
KR (1) KR100612547B1 (enExample)
CN (1) CN1263509C (enExample)
AR (1) AR016987A1 (enExample)
AT (1) ATE345815T1 (enExample)
AU (1) AU743759B2 (enExample)
BR (1) BR9910157A (enExample)
CA (1) CA2331086C (enExample)
CO (1) CO5050367A1 (enExample)
CY (1) CY1107322T1 (enExample)
CZ (1) CZ301232B6 (enExample)
DE (1) DE69934108T2 (enExample)
DK (1) DK1073462T3 (enExample)
ES (1) ES2277437T3 (enExample)
GB (1) GB9809507D0 (enExample)
GC (1) GC0000101A (enExample)
HU (1) HU228209B1 (enExample)
IL (1) IL139269A0 (enExample)
MY (1) MY128929A (enExample)
NO (1) NO20005483L (enExample)
NZ (1) NZ507902A (enExample)
PL (1) PL190729B1 (enExample)
PT (1) PT1073462E (enExample)
TR (1) TR200003235T2 (enExample)
TW (1) TW553744B (enExample)
WO (1) WO1999056772A2 (enExample)
ZA (1) ZA200006118B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
IL283039B2 (en) * 2018-11-13 2025-01-01 Variation Biotechnologies Inc Immunological preparations for the treatment of hepatitis B

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DE122010000016I1 (de) * 1992-05-23 2010-07-08 Glaxosmithkline Biolog Sa Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
DE69731357T2 (de) * 1996-03-23 2006-02-02 The Research Foundation For Microbial Diseases Of Osaka University, Suita Funktionelles antigenfragment von tetanustoxin und tetanusvakzine

Also Published As

Publication number Publication date
AR016987A1 (es) 2001-08-01
CN1308547A (zh) 2001-08-15
HUP0101652A3 (en) 2004-10-28
KR20010043224A (ko) 2001-05-25
CZ20004061A3 (cs) 2001-04-11
PL190729B1 (pl) 2005-12-30
CO5050367A1 (es) 2001-06-27
DE69934108T2 (de) 2007-04-19
MY128929A (en) 2007-02-28
AU4137999A (en) 1999-11-23
CZ301232B6 (cs) 2009-12-16
JP5138843B2 (ja) 2013-02-06
NZ507902A (en) 2002-03-28
ZA200006118B (en) 2002-01-30
HU228209B1 (en) 2013-01-28
IL139269A0 (en) 2001-11-25
TR200003235T2 (tr) 2001-03-21
KR100612547B1 (ko) 2006-08-11
WO1999056772A2 (en) 1999-11-11
BR9910157A (pt) 2001-01-09
ATE345815T1 (de) 2006-12-15
CN1263509C (zh) 2006-07-12
GB9809507D0 (en) 1998-07-01
NO20005483D0 (no) 2000-10-31
EP1073462A2 (en) 2001-02-07
NO20005483L (no) 2000-12-08
DK1073462T3 (da) 2007-02-26
CY1107322T1 (el) 2012-11-21
CA2331086A1 (en) 1999-11-11
PL344137A1 (en) 2001-10-08
GC0000101A (en) 2005-06-29
WO1999056772A3 (en) 2000-02-03
TW553744B (en) 2003-09-21
AU743759B2 (en) 2002-02-07
DE69934108D1 (de) 2007-01-04
PT1073462E (pt) 2007-01-31
JP2002513771A (ja) 2002-05-14
HUP0101652A1 (hu) 2001-09-28
EP1073462B1 (en) 2006-11-22
HK1034202A1 (en) 2001-10-19
JP2010209118A (ja) 2010-09-24
CA2331086C (en) 2010-06-22

Similar Documents

Publication Publication Date Title
ES2164251T5 (es) Vacuna que comprende un conjugado antigeno polisacarido-proteina transportadora y proteina transportadora libre.
EP2066344B2 (en) Inactivated Poliovirus combination vaccine
JP5232006B2 (ja) Ｂ型肝炎ウイルス表面抗原および界面活性剤の両方を含むワクチンの製造
ES2240647T7 (es) Vacuna de pertussis acelular con toxoides de difteria y tetanos.
CZ283910B6 (cs) Kombinovaný očkovací prostředek, způsob jeho výroby a použití fosforečnanu hlinitého jako pomocného prostředku
AU1000802A (en) Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid_A
JP2010209118A (ja) 新規組成物
Jilg Novel hepatitis B vaccines
JP2008536515A (ja) ワクチンの調製のためのｂ型肝炎ウイルス表面抗原の発現
US7144703B2 (en) Composition
HK1034202B (en) Combined vaccine against hepatitis a and hepatitis b
JP2000511553A (ja) ボルデテラ・ペルツッシスの外膜タンパク質フラグメントを有してなるワクチン組成物
PL174077B1 (pl) Szczepionka do ochrony przed zakażeniem lub leczeniem zakażeń Hepatitis B i heterologicznych chorób, zawierająca antygen powierzchniowy Hepatitis B (HBsAg)